One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles

dc.contributor.authorKumar, Dalip
dc.date.accessioned2021-10-27T04:20:57Z
dc.date.available2021-10-27T04:20:57Z
dc.date.issued2011-04
dc.description.abstractA series of 2-arylamino-5-aryl-1,3,4-thiadiazoles 1a–j were synthesized and screened for their anticancer activity against various human cancer cell lines. The novel one-pot synthesis of 1,3,4-thiadiazoles was achieved by refluxing aryl aldehydes, hydrazine hydrate, and aryl isothiocyanates in methanol followed by oxidative cyclization with ferric ammonium sulfate. The compounds 1g–j with trimethoxyphenyl at the C-5 position displayed extremely potent anticancer activity with at least twofold selectivity (IC50: 4.3–9.2 μM). The nature of substituent on the C-2 arylamino ring may be critical in opting for the selectivity towards a particular cancer cell.en_US
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0960894X11002678?via%3Dihub
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/3053
dc.language.isoenen_US
dc.publisherElsieveren_US
dc.subjectChemistryen_US
dc.subject1,3,4-Thidiazolesen_US
dc.subjectAnticancer agentsen_US
dc.subjectOne-pot synthesisen_US
dc.subjectCancer cell linesen_US
dc.subjectOxidative cyclizationen_US
dc.titleOne-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazolesen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: